ENGLEWOOD, Colo., Sept. 26, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSEAmerican:AMPE) (the "Company") a pre-revenue stage biopharmaceutical Company focused on development of a potential treatment for osteoarthritis as part of its OA.201 program, today announced that its CEO, Michael A. Martino will present in the Emerging Growth Conference on Thursday, October 5, 2023 at 3:25 pm ET.
Read more at prnewswire.comAmpio Pharmaceuticals to Present at the Emerging Growth Conference
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here